Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D5GI0O
|
|||
| Drug Name |
VIMO-001
|
|||
| Synonyms |
alpha-tocopheryloxyacetic acid; alpha-TEA; JW7FJR3ZLY; UNII-JW7FJR3ZLY; aTEA; 2-[[(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl]oxy]acetic acid; 261929-52-6; SCHEMBL2142535; CHEMBL2152999; DTXSID8041167; ZINC3974003; Q27896667; (2,5,7,8-Tetramethyl-(2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy)acetic acid; 2,5,7,8-Tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxyacetic acid; ({(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-chromen-6-yl}oxy)acetic acid; Acetic acid, (((2R)-3,4-dihydro-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl)oxy)-
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Breast cancer [ICD-11: 2C60-2C65; ICD-10: C50, C79.51] | Phase 1 | [1] | |
| Company |
Veana Therapeutics
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C31H52O4
|
|||
| Canonical SMILES |
CC1=C(C(=C(C2=C1OC(CC2)(C)CCCC(C)CCCC(C)CCCC(C)C)C)OCC(=O)O)C
|
|||
| InChI |
1S/C31H52O4/c1-21(2)12-9-13-22(3)14-10-15-23(4)16-11-18-31(8)19-17-27-26(7)29(34-20-28(32)33)24(5)25(6)30(27)35-31/h21-23H,9-20H2,1-8H3,(H,32,33)/t22-,23-,31-/m1/s1
|
|||
| InChIKey |
LCFWOFKPFDWYLR-CEFNRUSXSA-N
|
|||
| CAS Number |
CAS 261929-52-6
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Veana Therapeutics. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.